ABOUT 

Bill Douglass is founder and Managing Principal of Gotham Private Capital. He concurrently runs Gotham Communications, a strategic communications agency that he founded in 2009. Clients have included Index Ventures, Ambry Genetics (sold to Konica Minolta for $1 Billion), Advanced Cell Technology (sold to Astellas Pharma, as covered in The New York Times), and XO1 Ltd. (sold to Johnson & Johnson), as well as family offices, hedge funds and other private equity firms.

Bill currently serves on the Brain Targeting Program (BTP) Advisory Board at the Wyss Institute at Harvard University.

From 2022 to 2023, Bill was on the management team at Hevolution Foundation, a life sciences investor and grant-making organization with an annual budget of up to $1 Billion, reporting to the CEO and serving on the Executive Committee.

A Registered Representative of Stonehaven, LLC, Member FINRA/SIPC, Bill holds the Uniform Securities Agent license (Series 63) and the Private Securities Offerings Representative license (Series 82). He attended Boston University’s College of Communication and earned a BA from the University of Houston. He has spoken at a variety of conferences, including Reuters’ HedgeWorld, IMN Alpha Hedge West, Activist Investing in Canada, and the Horasis Global Meeting.

Bill’s writings have been published in The Economist and elsewhere, and in January 2026 he was cited as an expert on future technology by BBC News.

Having worked across six continents and with deep professional experience in East Asia and the Middle East, Bill has built an international network of contacts. He lives in Fairfield County, Connecticut, outside New York City, with his wife – a practicing physician – and their two children.